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Abstract
Background: Governments increasingly require policy documents to be evidence-based. This
paper analyses the use of scientific evidence in such documents by reviewing reports from
government-appointed committees in Norway to assess the committees' handling of questions of
effect.
Methods: This study uses the 'Index of Scientific Quality' (ISQ) to analyse all Norwegian official
reports (NOUs) that were: (1) published by the Norwegian Ministry of Health and Care Services
during 1994-1998 (N = 20); and (2) concerned with questions of effect either because these were
included in the mandate or as a result of the committee's interpretation of the mandate. The ISQ
is based on scientific criteria common in all research concerning questions of effect. The primary
outcome measure is an ISQ score on a five-point scale.
Results: Three reports were excluded because their mandates, or the committees' interpretations
of them, did not address questions of effect. For the remaining 17 NOUs in our study, overall ISQ
scores were low for systematic literature search and for explicit validation of research. Two
reports had an average score of three or higher, while scores for five other reports were not far
behind. How committees assessed the relevant factors was often unclear.
Conclusion: The reports' evaluations of health evidence in relation to questions of effect lacked
transparency and, overall, showed little use of systematic processes. A systematic, explicit and
transparent approach, following the standards laid down in the ISQ, may help generate the
evidence-based decision-making that Norway, the UK, the EU and the WHO desire and seek.
However, policy-makers may find the ISQ criteria for assessing the scientific quality of a report too
narrow to adequately inform policy-making.
Background
Nearly 30 years ago, Lindblom and Cohen stated: '... in
public policy making, many suppliers and users of social
research are dissatisfied, the former because they are not
listened to, the latter because they do not hear much they
want to listen to' [1]. Twenty years later, the British gov-
ernment asked for policy that was 'shaped by the evidence
rather than a response to short-term pressures' [2]. This
quest for evidence by the British government exemplified
a new trend in modern policy-making and, since the early
1990s, the success of evidence-based medicine has gener-
ated calls for, and discussions of, evidence-based policy-
making [3-11]. This trend has been encouraged by inter-
national institutions such as the EU and WHO [12-14].
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A call for evidence-based policy-making is also a call for
the use of scientific methods in data collection and in the
validation of information. Whenever policies are dis-
cussed, the question is often simply, "What will work?"
Accordingly, when making priorities and formulating
healthcare policies, a key factor will be evidence of their
effects. A transparent and explicit approach is essential for
reliable, valid and rational decision-making.
In interview studies, policy-makers state that three factors
will facilitate their use of scientific evidence in policy deci-
sions: high quality research; the inclusion of data on effec-
tiveness; and summaries with clear recommendations
[1,15-18]. If research studies are to have a greater impact
in decision-making, this means it is important to assess
the quality of such a vital element in official policy docu-
ments.
Previous studies of health policy documents commis-
sioned in the UK and elsewhere and by the WHO have
investigated the consistency of suggested policies with evi-
dence gathered in the field [14,19-23]. Studies of docu-
ments commissioned in the UK have revealed a lack of
consistency between recommendations and best evidence
[20].
In 2002, the Norwegian government stated that it wished
to adopt the evidence-based approach to policy-mak-
ing[12]. In Norway, the government and the parliament
frequently commission comprehensive reports, known as
Norwegian official reports (NOUs), which deal with com-
plex policy questions of national importance [24]. In such
cases the government nominates a committee to write the
report on the basis of a set of relevant questions (the man-
date). NOUs are clearly the government policy documents
that make most reference to research evidence. Similar
reports exist in Sweden and in both countries these reports
resemble a hybrid of British green papers and commis-
sioned reports. There are many studies of health policy-
makers' perceptions of their use of evidence, but only few
studies of their actual use of evidence [15]. This paper
presents an empirical study that examines how scientific
evidence is used in policy documents by reviewing reports
from government-appointed committees in Norway to
assess their handling of questions of effect.
Methods
All NOUs published by the Norwegian Department of
Health and Care Services during 1994-1998 were col-
lected and those that reported evidence of health effects
were included in this study. Of the 20 NOUs published
during the study period, three were excluded either
because the mandates did not address questions of effect
or because the committees did not interpret the mandates
as doing so, resulting in a total of 17 analysed NOUs. A
full list of titles appears in Table 1.
Analytical strategy
Each NOU included within the study was circulated
between four researchers (see the acknowledgements at
the end of the paper) until general agreement was reached
regarding the relevant questions of effect in the mandate
or the committee's interpretation of the mandate. The
same researchers then worked in pairs to score all the
reports using a predefined set of evaluation questions.
Group discussions were then held to resolve opposing
views. We also analysed the composition of each commit-
tee, i.e., the relative importance of the roles of researchers,
policy-makers and representatives from interest organisa-
tions.
Table 1: NOUs from the Department of Health and Care Services, from 1994 through 1998
1. From paid work to retirement. NOU 1994: 2 2. The use of cells and tissues from aborted embryos. NOU 1994: 22
3. Programme for health and social services for the Sami population in 
Norway. NOU 1995: 6
4. Regional institutions for patients in need of long-term care. NOU 
1995: 14
5. Electromagnetic fields and public health. NOU 1995: 20 6. Alcohol policy -- in need of change? NOU 1995: 24
7. The patient first: leadership and management of hospitals. NOU 
1997: 2
8. Framework for sale and distribution of pharmaceuticals. NOU 1997: 
6
9. Alternative medicine. NOU 1998: 21 10. Pharmaceuticals: priorities and policies. NOU 1997: 7
11. Priorities revisited -- guidelines for making priorities in Norwegian 
healthcare. NOU 1997: 18
12. Care and knowledge: the Norwegian cancer programme. NOU 
1997: 20
13. Eradication of tuberculosis? A strategy for future tuberculosis 
control. NOU 1998: 3
14. Air ambulances in Norway. NOU 1998: 8
15. Emergency needs. Professional skills for emergency preparedness. 
NOU 1998: 9
16. The Alta battalion. NOU 1998: 12
17. Everyone is needed. NOU 1998: 18
Excluded NOUs (because mandates did not address questions of effect):
Co-ordination of public pensions and insurance payments. NOU 1995: 29
Financing and out-of-pocket payment for care services. NOU 1997: 17
Access to health registers. NOU 1997: 26BMC Health Services Research 2009, 9:177 http://www.biomedcentral.com/1472-6963/9/177
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The predefined questionnaire for evaluating the NOUs
consisted of four main components (table 2).
The first component, concerning the mandate's descrip-
tion of the task, was included to clarify whether the com-
mittee was supposed to evaluate evidence of effect. The
purpose of the second component, concerning the strat-
egy used by the committee to gather research information,
was to ascertain whether the intentions of the committee
were research-based, how the committee proceeded to
gather information, and the sources of its data.
The third component concerned the use of evidence in the
report's recommendations and summary. Research sug-
gests that policy-makers often rely heavily on these aspects
of reports, making an assessment of their scientific quality
particularly important [15]. The special guidelines used to
address this third component of the evaluation appear in
Table 3.
The fourth component concerned the quality of the scien-
tific evidence. To assess the use of scientific evidence in the
reports, we applied the Index of Scientific Quality (ISQ)
[25,26]. The ISQ is based on common scientific criteria in
all research based on rigorous methods that aims to
answer questions of effect. The ISQ criteria are presented
in Table 4.
The index is based on a five-point scale, with a score of 5
representing the highest level of scientific quality. Accord-
ing to the ISQ criteria for documentation (question B),
clear references to the evidence will score 4 or 5, while
partly unclear or definitely unclear references to evidence
will score 2 or 3, depending upon the degree of uncer-
tainty. When references to evidence are potentially mis-
leading, the ISQ score will be 1 or 2. Table 4 shows the
guidelines used for scoring each of the eight questions
concerning the committees' handling of scientific evi-
dence. Reports of low overall quality will score 1 or 2,
indicating extensive shortcomings in relation to several
ISQ criteria. Reports of high overall quality, with few
shortcomings, will score 4 or 5.
Limitations of this study
Previously the ISQ has mainly been used by studies eval-
uating health reporting in newspapers. We know of no
other studies that have used the ISQ to evaluate govern-
mental reports. A few reservations are relevant regarding
the use of the index in this context. Firstly, public policy
formation is clearly much more complicated than the dis-
cussion here might suggest. In addition to scientific evi-
dence, policy-makers need to weigh up different factors
such as the values of stakeholders, budgets, cost-effective-
ness, broader perspectives, political decisions and aims,
other, perhaps more relevant, evidence than the existing
evidence of effect, prudent practices, and commonsense
understandings that are obvious, but not supported by
research evidence. As a consequence, evidence of effect
will only form one aspect of the decision-making process
when evidence-based policies are made [8,27]. Discus-
sions of other approaches to evaluating evidence are inter-
esting, but outside the scope of this paper [9,11,28-41].
Secondly, questions may be raised regarding the sensibil-
ity of the ISQ. A comprehensive sensibility analysis of the
ISQ [25,26] found the index to be acceptably reliable and
Table 2: The four main components For evaluating reports
1. The mandate's description of the task
Was the committee asked to evaluate: (Yes/No)
A. The extent and the seriousness of the problem? B. The effectiveness of services in meeting needs created by the 
problem?
C. Alternative services? D. Economic consequences?
E. Values, such as the preferences of patients or ethical considerations?
2. The strategy used by the committee to gather research information (Yes/No)
A. Did the report state that it was based upon research? B. Did the report state how research was identified?
3. The use of evidence in recommendations and in the summary (Score 1-5)
A. Recommendations: Does the committee clearly state how it weighed 
up health needs, the effectiveness of treatment, economic concerns, and 
other values?
B. Is the summary clearly structured and easily understood by non-
professionals?
4. Evaluation of the quality of scientific evidence (Score 1-5)
A. Relevance: Does the report make it clear for whom the results are 
relevant?
B. Documentation: Does the presented evidence rely on research, and 
are references given?
C. Validity: Is the assessment of the validity of the evidence clear and 
well-founded?
D. Size of effects: Is the size of effects clearly described?
E. Precision: Are confidence intervals identified and evaluated when 
relevant?
F. Consistency: Are the findings consistent?
G. Consequences: Are the main consequences identified and assessed? H. Overall quality: What is the overall scientific quality?BMC Health Services Research 2009, 9:177 http://www.biomedcentral.com/1472-6963/9/177
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credible. Only one major problem was identified: the
need to apply judgment when awarding scores. We also
encountered this problem, but were able to resolve our
initial and minor disagreements through discussion.
Thirdly, a more contextual evaluation of the variations in
scores, or treating each NOU as a separate case, could give
important insights into the nature of the variations. An
example of this problem arises in connection with one of
the NOUs about the Norwegian cancer programme,
where narrow questions of effect can only make a minor
contribution to a broad mandate.
Finally, the analysed reports are not the most recent ones,
so they may not be representative for recent NOUs. And a
move to promote evidence-based policy making in Nor-
way appears to have been made in January 2004, with the
formation of an institution called The Norwegian Knowl-
edge Centre for the Health Services (NKCHS). The Centre
is organised and funded by the Norwegian Directorate of
Health. NKCHS is meant to be scientifically and profes-
sionally independent. The Centre has two overarching
tasks: The first is to promote evidence-based policy mak-
ing, by producing health technology assessment reports,
systematic reviews, overviews and reports that provide
policy makers with early warnings. The second task is to
support health services at all levels to incorporate evi-
dence into their practices.
The NOUs published during 1994-1998 seem to be repre-
sentative of the 19 NOUs published from 1999 to the
present. There have been no significant changes in the for-
mal framework for preparing these reports, although
some minor revisions were implemented in 2005. Only a
shallow investigation of the 19 NOUs published since
1999 is necessary to confirm that when committees inter-
pret their mandates and design their reports, they do not
utilize a systematic approach that is similar to the ISQ or
familiar evidence-based approaches. Generally speaking it
is still the government-appointed committee that deter-
mines the methods and procedures used to produce the
report. Only one of the NOUs published after 1998
reported that the committee preparing the report asked
the NKCHS for a review of the relevant research. The
NKCHS responded by stating that such a report would
take the Centre from 6 to 24 months to produce. The com-
mittee deemed this to be beyond the framework provided
to it to complete its work.
Results
The themes of the reports varied from broad policy issues,
such as the setting of healthcare priorities, to narrower
issues such as the health consequences of particular stim-
uli (e.g., electromagnetic fields). Some reports spanned a
number of topics, such as those covering health and social
services among the Sami population or public health serv-
ices in local communities.
Task specification in the mandates
Some mandates specified objectives relating to the organ-
isation of care, e.g., 'How should care be organised to give
the best medical and social outcomes for patients with
multiple sclerosis?' Other mandates posed more concrete
questions: 'Will dramatic experiences during war cause
long-term psychiatric problems in soldiers?' 'What is the
effect of directly observed treatment for patients suffering
from tuberculosis?' The mandates were short, generally a
half to one page in length. Most mandates required the
Table 3: Questions concerning recommendations and summaries
Question A
In making its recommendations, did the committee clearly state how it weighed up health needs, effectiveness, resources and values?
No Partial Yes
The committee does not 
state how it weighed up 
health needs, effectiveness, 
resources other values.
The committee made some explicit statements, but these 
are not sufficient for a full understanding of how the 
committee reached its conclusions.
There was an explicit evaluation of health needs, 
effectiveness, resources and values
12345
Question B
Is the summary clearly structured, and can non-professionals easily understand it?
No Partial Yes
The content of the report 
is not clearly described. 
The summary is difficult to 
read, unstructured, or 
does not provide a good 
account of the content 
(too long, too short).
The content of the report is, to some extent, presented 
in the summary, but there are some shortcomings in 
clarity (difficult language) and structure. The summary is 
either too long or too short.
The summary is easy to read and and well structured. 
The summary is neither too long nor too short.
12345BMC Health Services Research 2009, 9:177 http://www.biomedcentral.com/1472-6963/9/177
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committee to consider the following issues: need (15); the
effectiveness of relevant interventions (16); and economic
implications (15). None of the mandates specified the
type or quality of data required. Six of the 17 mandates
analysed required a discussion of relevant values, such as
the preferences of patients, public considerations, or
juridical or ethical consequences.
Strategies used by committees to gather research 
information
Some committees consisted mainly of experts in the rele-
vant field, while other committees consulted external
experts and included their recommendations as appendi-
ces to their reports. Expert participation on the commit-
tees did not appear to influence the strategy used for
information gathering. While all the reports but one
referred to reliance upon research, none of the reports
described the procedures or literature searches used to
gather research information on the harm or efficacy of rel-
evant interventions. Although one report (on electromag-
netic fields) stated that it included all the relevant
literature, it provided no information about how the liter-
ature search had been conducted. Another report (on
complementary medicine) stated that various organisa-
tions had been asked to provide relevant publications, but
did not state the type of literature requested.
The use of evidence in recommendations and in the 
summary
Component 3 in table 2 assesses how the committee eval-
uated the various considerations of health needs, effec-
tiveness, resources and values when making its final
recommendations. The average score was 2.9, indicating
medium quality. Two reports scored 3.0 or above. The
Table 4: Questions Concerning evaluation of the quality of scientific evidence
Question A. Relevance: Is it clear to whom the information in the report applies?
No Partial Yes
Potentially misleading Minor lack of clarity. Minimal ambiguity
12345
Question B. Documentation: Does the presented evidence rely on research, and are references given?
No Partial Yes
Potentially misleading Statements are attributed to sources, but the underlying 
evidence is ambiguous
The evidence underlying the main points is clearly cited
12345
Question C. Validity: Is the assessment of the credibility of the evidence clear and well-founded?
No Partial Yes
Not done or potentially 
misleading
Study design or type of evidence reported but not 
properly assessed
Strengths of the research methods adequately assessed
12345
Question D. Size of effect: Is the strength of the findings (effects) clearly reported?
No Partial Yes
Not done or potentially 
misleading
The magnitude of effects is reported incompletely or 
ambiguously
Magnitude of effects clearly reported
12345
Question E. Precision. Are confidence intervals identified and evaluated when relevant?
No Partial Yes
Not done or potentially 
misleading
Indirectly or incompletely Confidence intervals adequately assessed
12345
Question F. Consistency: Is the consistency of the evidence (between studies) considered?
No Partial Yes
Not done or potentially 
misleading
More than one study is discussed, but consistency is not 
clearly reported
Number of studies and consistency clearly reported
12345
Question G. Consequences: Are the main consequences (benefits, risks and costs) identified and assessed?
No Partial Yes
Potentially misleading Important consequences are not considered Most important consequences are are clearly identified
12345
Question H. Overall quality: Based on the answers to the above questions, how would you rate the overall scientific quality?
Low Moderate High
Critical or extensive 
shortcomings
Potentially important but not critical shortcomings Minimal shortcomings
12345BMC Health Services Research 2009, 9:177 http://www.biomedcentral.com/1472-6963/9/177
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committees responsible for the 15 remaining reports (88
per cent) gave partly unclear descriptions of how they
reached their conclusions. In general the committees pro-
vided relatively clear and structured summaries, with an
average score of 3.4. Ten NOUs scored 4, while only three
scored below 3.0.
Evaluation of the quality of scientific evidence
The 17 NOUs were evaluated through the application of
seven criteria to assess the quality of scientific evidence.
This produced 119 evaluations distributed on a five-point
scale. The scores for all 119 evaluations appear in Figure 1.
In general, evidence of harm and evidence of effectiveness
were presented in combination with information about
preferences and problems concerning access to, and avail-
ability of, health services. Fifty of the 119 evaluations (42
per cent) resulted in scores ranging between 3 and 5. Only
15 evaluations (13 per cent) resulted in scores exceeding
4.0. Sixty-nine of the 119 evaluations (58 per cent) only
scored 1 to 2. In short, these results suggest that more than
half of the evaluations identified insufficient descriptions
and assessments of the quality of evidence of effect.
Figure 2 shows the average score in relation to each ques-
tion in the ISQ (see table 4).
Question A asked whether the report made clear the spe-
cific population for whom the report was relevant. Question A
produced an average score of 3.1, the only average score to
exceed 3.0. While most reports were partly unclear about
the population for whom they were relevant, many also
provided important and relevant information. Question B
asked whether the presented evidence relied on research and
whether the reports referred properly to the research. The aver-
age score here was 2.3. Only two reports specified refer-
ences for the most important information.
Question C concerned the assessment of study quality. Only
two reports provided details of study design and only one
described how the committee had assessed the quality of
the evidence. The average score here was 1.5. Question D
concerned the reporting of the size of the effect and pro-
duced an average score of 2.1. Question E asked about the
precision with which the effect had been measured and pro-
duced an average score of 1.6. Many reports described
interventions as 'effective', but none reported the magni-
tude of the most significant effects. Questions C and E
produced the lowest scores, both with an average slightly
exceeding 1.5.
Only one report attained a score of 5 for its consideration
of how the evidence presented related to other findings in
the field (question F on attention given to consistency
between studies). The average score for question F was
2.2. We identified discussions concerning more than one
study in five reports. These were awarded scores of 3. The
other 11 reports scored only 1 or 2 as they provided either
potentially misleading information or no information at
all about consistency between studies. As a general com-
ment, committees that, for example, only identify a single
research study relevant to their report should at least dis-
cuss whether this is the result of a low-quality literature
search. In cases where there is only one study dealing with
a given question of effect, an evidence-based evaluation
should include an assessment of the robustness of the evi-
dence.
Question G dealt with the reports' assessments of the
interventions' most significant consequences related to ben-
efits, risks and costs. Only two reports scored above 3. The
average score was 2.8. Question H on overall quality
required a global evaluation of each report, resulting in an
average score of 2.3.
Figure 3 shows the average ISQ score for each report.
ISQ scores were generally low. Average scores for seven
reports (41 per cent) were above or just under 3.0. These
reports generally provided important scientific informa-
tion regarding questions of effect. Only one report had an
average score exceeding 4.0, while one other report scored
above 3.0. There was a wide range of average scores, since
while one report failed to describe the effectiveness of the
services suggested and therefore scored 1 on all questions,
another received high scores all round.
Discussion
Systematic reviews of the outcomes of randomised con-
trolled trials have probably been the key element in the
development of evidence-based medicine. Systematic
reviews assess search strategies and carry out critical
appraisals. The ISQ is based upon the same principles as
Scores for all the 119 judgements on scientific quality (1-5  scale) (See box 3 for the 7 judgements for 17 NOUs, N =  119, overall quality not included) Figure 1
Scores for all the 119 judgements on scientific quality 
(1-5 scale) (See box 3 for the 7 judgements for 17 
NOUs, N = 119, overall quality not included).
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those underlying systematic reviews. Ministries, the gov-
ernment, and parliament rely on NOUs to provide the
most comprehensive advice on subjects of national
importance. Our analysis suggests that more than half of
NOUs dealing with healthcare contain inadequate
descriptions and assessments of the quality of the evi-
dence of effect. We are not suggesting that NOUs provide
the public with low-quality reports, merely that their sci-
entific quality regarding questions of effect is low.
Our study suggests that committees prioritise policy rele-
vance, as the NOUs included in the study primarily
focused on policy relevance and policy implications. In
both respects we found the reports' use of scientific evi-
dence to be generally mediocre. We identified a lack of
clarity regarding both the reports' primary intended audi-
ence and the identification and assessment of the main
consequences of the study. There was insufficient treat-
ment of validity and precision in relation to hard science
questions. This may arise from a belief among the authors
of reports that policy-makers are uninterested in the sci-
ence underlying committee recommendations. Commit-
tees may also not consider their time and resources best
spent teaching policy-makers about scientific standards.
It is impossible to be sure why committees give lower pri-
ority to hard science questions, since we have no data
from interviews with committee members. We do know,
however, from a systematic review of interview studies
concerning health policy-makers' perceptions of their use
of evidence, that policy-makers want summaries that
make clear recommendations [15]. The committees may
focus on relevance and consequences simply because they
believe this is what policy-makers primarily want and find
useful in decision-making. There is some support for this
inference in our finding that the scientific quality of the
reports is highest where evidence is used in the recom-
mendations and in the summary. Our findings suggest
that both policy-makers and experts tend to prioritise
summaries and recommendations, rather than the hard
science underlying them, since experts' participation on
committees did not seem to influence the strategy used to
gather research information.
The fact that seven reports obtained an average ISQ score
of below 2.0 suggests that committees give insufficient
attention to the assessment of scientific evidence. In other
words, policy-makers must look elsewhere for transparent
descriptions of search strategies for literature, references to
evidence gathered in the field, and assessments of the evi-
dence of effect. Our raw data indicates that questions of
effect escaped the committees' attention in three of the
seven reports, making their ISQ scores of 1 or 2 hardly sur-
This figure displays a graphs expressing Average scientific index for the 8 questions on quality Figure 2
This figure displays a graphs expressing Average scientific index for the 8 questions on quality.
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prising. We have no information about why some of the
committees largely avoided questions of effect.
The mandates typically posed broad questions, rather
than clear-cut questions of effect. Although NOUs were
only included in our study if questions of effect were rele-
vant to their mandates, these questions of effect were
sometimes rather implicit and were always connected to
broader issues and to a broader mandate. Since NOUs are
intended to deal with questions of national importance,
their mandates will naturally be broad. It is easy to imag-
ine the broad mandate for the NOU report 'Care and
knowledge: the Norwegian Cancer Programme', which
deals with a variety of topics, such as: definitions of can-
cer; cancer as a national problem; the social consequences
of cancer; care structures and processes for cancer suffer-
ers; and the administrative and organisational conse-
quences. Within the time span allotted for producing a
report of this nature, it is very difficult for a committee to
carry out a comprehensive review of questions of effect.
When reviewing cancer treatments, it is also of course dif-
ficult to decide where to focus. Even if there is a decision
to focus on breast cancer (instead of, for example, lung
cancer or childhood cancer), it will still be necessary to
select from the many different questions of effect in the
treatment of breast cancer. Even a narrow focus on 10 dif-
ferent questions of effect with a protocol in the Cochrane
library will still exclude more than 50 other protocol ques-
tions in the same database [42]. Let us suppose that an
NOU dealing with a Norwegian cancer programme dealt
with 10 questions of effect in the treatment of breast can-
cer. Even if the report were written in such a way as to
receive top ISQ scores, it would still tell us little about the
Norwegian cancer programme. An NOU that answers a
broad mandate by focusing narrowly on questions of
effect is less useful for policy-makers.
Conclusion
Politicians, scientists, bureaucrats, experts and lay people
often have (quite legitimately) differing interests. If public
governmental reports refer to evidence in an explicit and
transparent way, readers will largely be able to make reli-
able judgments by comparing the pros and cons apparent
from the evidence. Explicit and transparent references to
supporting evidence will assist in the identification of bias
rooted in special interests in the recommendations of gov-
ernmental reports.
This study shows that NOUs, in relation to their evalua-
tion of health effects, lack transparency and, overall, show
few signs of the use of systematic processes as far as scien-
This figure displays a graph illustrating Average scientific quality for each report Figure 3
This figure displays a graph illustrating Average scientific quality for each report.
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tific quality is concerned. A systematic, explicit and trans-
parent approach - in fact, an approach that would
generate a high ISQ score - may encourage the develop-
ment of the evidence-based decision-making that Norway
and other nations and international institutions desire
and seek.
Some people might object that applying the ISQ criteria
would overly narrow the focus of reports and cause the
omission of other kinds of information more relevant for
policy-makers: instead of promoting democratic debate,
application of the ISQ criteria might lead to meritocracy.
However, such objections would be convincing only if
reports scoring highly on the ISQ criteria were inherently
difficult for politicians, bureaucrats, experts and lay peo-
ple to understand. Instead of rejecting out of hand the
possibility of writing understandable reports of high sci-
entific quality, committees should focus on writing
reports that are accessible to academics and non-academ-
ics alike. Committees that include experts as well as non-
experts should make particular efforts in this regard. One
possible solution would be to prepare separate reports for
different audiences. The process of doing so might help
clarify the role of scientists in such committees and pro-
tect researchers from having their results abused [29,43].
Research is a cumulative enterprise. Whether the ISQ is
useful for policy-making, and whether a narrow focus on
questions of effect helps policy-makers make wise deci-
sions remains to be seen. The ISQ cannot and should not
exclude politics from evidence-based policy-making. But
if calls by governments for evidence-based policy-making
are to be taken seriously, we need to develop and test evi-
dence-based approaches such as those endorsed by the
ISQ so that evidence-based policy may progress from aspi-
ration to reality.
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